Latest filing published 02 Jan 2018 for Acura Pharmaceuticals, INC, €186k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Claudius LLC: trading record in brief
Claudius LLC has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Medassets Inc and Acura Pharmaceuticals, Inc. The record holds 165 filings, for trades running from 11 September 2008 to 14 December 2017.
The open-market record consists of 163 sales worth €19.0M, with no purchase. So far in 2018, the count stands at no purchases and 1 sale.
The latest filing, published on 2 January 2018, reports an open-market sale of €186k in Acura Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Claudius LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,195,734 shares@ US$0.10Common StockSEC:0001209191-18-000346:0
- 100,923 shares@ US$1.0844Common StockSEC:0001209191-15-054770:0
- 3,900 shares@ US$1.05Common StockSEC:0001209191-15-054770:1
- 100,000 shares@ US$0.6018Common StockSEC:0001209191-15-003773:0
- 36,000 shares@ US$0.651Common StockSEC:0001209191-15-003773:1
- 35,000 shares@ US$0.6416Common StockSEC:0001209191-15-003773:2
- 21,602 shares@ US$2.0054Common StockSEC:0001209191-14-022631:0
- 2,500 shares@ US$2.00Common StockSEC:0001209191-14-017134:0
- 6,301 shares@ US$1.9512Common StockSEC:0001209191-14-015475:0
- 5,000 shares@ US$1.9545Common StockSEC:0001209191-14-015475:1
- 192,479 shares@ US$2.0415Common StockSEC:0001209191-14-015475:2
- 147,480 shares@ US$2.0054Common StockSEC:0001209191-14-015475:3
- 272 shares@ US$1.95Common StockSEC:0001209191-14-014103:0
- 43,747 shares@ US$1.9664Common StockSEC:0001209191-14-014103:1
- 2,200 shares@ US$1.95Common StockSEC:0001209191-14-012427:0
- 4,200 shares@ US$2.05Common StockSEC:0001209191-13-048236:0
- 200,000 shares@ US$2.15Common StockSEC:0001209191-13-035727:0
- 20,446 shares@ US$2.15Common StockSEC:0001209191-13-032999:0
- 3,469 shares@ US$2.20Common StockSEC:0001209191-13-032295:0
- 27,814 shares@ US$2.15Common StockSEC:0001209191-13-032295:1
- 11,796 shares@ US$2.19Common StockSEC:0001209191-13-031650:0
- 9,700 shares@ US$2.21Common StockSEC:0001209191-13-031650:1
- 22,802 shares@ US$2.21Common StockSEC:0001209191-13-031238:0
- 6,650 shares@ US$2.21Common StockSEC:0001209191-13-031238:1
- 10,001 shares@ US$2.13Common StockSEC:0001209191-13-031238:2
25 of 144 declarations
